# Verano Holdings Corp.

> Clarifo company profile — qualitative business description generated from
> the company's filings. Financial statements, charts and ratios are
> available on Clarifo (https://www.clarifo.com/fi/companies/Verano Holdings Corp.).

## Overview

Verano Holdings Corp. is a U.S.-based cannabis company organized as a holding company with operating subsidiaries across multiple states. It cultivates, processes, distributes, and sells cannabis products through wholesale channels and branded retail dispensaries under banners such as Zen Leaf and MÜV.

## Products & services

• Cannabis cultivation and processing
• Wholesale distribution of cannabis products
• Branded retail dispensaries
• Medical-use cannabis products
• Adult-use cannabis products
• Consumer brands and packaged goods

- **Wholesale cannabis products** (32%) — Cultivated and processed cannabis sold to third-party retailers and company stores.
- **Retail dispensary sales** (68%) — Cannabis sold directly to patients and consumers through owned dispensaries.
- **Medical cannabis** (53%) — Regulated cannabis products sold for medical-use markets.
- **Adult-use cannabis** (47%) — Cannabis products sold in recreational-use markets.

- Cannabis cultivation and processing
- Wholesale distribution of cannabis products
- Branded retail dispensaries
- Medical-use cannabis products
- Adult-use cannabis products
- Consumer brands and packaged goods

## Customers

Verano sells to two main customer groups: retail patients and adult-use consumers who buy through its dispensaries, and third-party cannabis retailers that purchase wholesale product. Its medical customers typically seek regulated access and consistent product availability, while adult-use customers buy branded flower, concentrates, edibles, and topicals through local dispensaries.

- **Medical patients** (primary) — Buy regulated cannabis products through dispensaries for medical-use needs and consistent access.
- **Adult-use consumers** (primary) — Purchase branded cannabis products for recreational use in state-legal markets.
- **Third-party retail dispensaries** (secondary) — Source wholesale cannabis products to stock shelves and expand assortment.
- **Cannabis brand shoppers** (secondary) — Buy specific branded SKUs such as Encore, Avexia, MÜV, Savvy, and Verano.

- Medical patients buying regulated cannabis for therapeutic use
- Adult-use consumers purchasing branded products at dispensaries
- Third-party retail stores sourcing wholesale cannabis inventory
- Customers seeking flower, concentrates, edibles, and topicals
- Dispensary shoppers served through brick-and-mortar locations

## Geography

Verano operates in 13 U.S. states and is concentrated in state-licensed cannabis markets rather than a single national footprint. The company’s retail revenues were highlighted in Florida, New Jersey, Illinois, Connecticut, Ohio, Massachusetts, Pennsylvania, and Virginia, reflecting a multi-state operating model with local regulatory exposure.

- **United States** (100%) — All operations and revenues are substantially U.S.-based

- Operations span 13 U.S. states
- Retail concentration includes Florida, New Jersey, and Illinois
- Expansion includes Connecticut, Ohio, Massachusetts, Pennsylvania, and Virginia
- Business depends on state-by-state cannabis licensing and regulation
- Local market maturity affects wholesale and retail mix

## Strategy

Verano’s strategy is to operate as a vertically integrated multi-state cannabis platform, combining cultivation, processing, wholesale distribution, and retail. It aims to scale branded products through its own dispensaries and third-party wholesale relationships while expanding its footprint in state markets as regulations allow.

- **Vertical integration across seed-to-sale operations** (medium-term) — Controls product flow from cultivation to retail and supports brand distribution at scale.
- **Expand retail footprint in state markets** (short-term) — More dispensaries increase direct customer access and brand presence.
- **Grow wholesale brand distribution** (medium-term) — Third-party retail customers broaden reach beyond owned stores.
- **Optimize cultivation and processing capacity** (medium-term) — Higher utilization supports supply reliability and operating leverage.

- Expand retail footprint through openings and acquisitions
- Scale cultivation and processing capacity across core markets
- Use vertical integration to support wholesale and retail channels
- Build brand loyalty through owned dispensaries and consumer brands
- Adapt market-by-market as state cannabis regulations evolve

## Risks

Verano’s business is exposed to U.S. cannabis regulation, including federal illegality, state licensing rules, and changing enforcement or rescheduling outcomes. It also faces industry-specific risks from price compression, competition, supplier dependence, and debt service, all of which can affect access to capital and operating flexibility.

- **Federal illegality of cannabis in the U.S.** [critical] — Cannabis remains regulated differently at the federal and state levels, creating legal and financing constraints.
- **State regulatory and political changes** [high] — Licenses, product rules, and market access depend on state law and local enforcement.
- **Wholesale price compression and competition** [high] — Mature state markets can see lower prices and more competitors, reducing unit economics.
- **Supplier and contractor dependence** [medium] — Packaging, construction, and other inputs are sourced from third parties and can be disrupted.
- **Indebtedness and refinancing risk** [high] — Debt service and covenant constraints can limit flexibility and capital allocation.

- Federal cannabis illegality creates legal and banking constraints
- State-by-state regulation can change licensing and operating rules
- Price compression can pressure wholesale and retail economics
- Supplier and contractor disruptions can affect packaging and buildouts
- Debt obligations increase sensitivity to cash flow and refinancing

## Accounting

Verano’s reporting is affected by revenue split between wholesale and retail channels, which can shift quarter to quarter as markets mature and stores open. Investors should also watch goodwill and indefinite-lived intangible asset impairment, lease accounting for dispensaries and cultivation sites, and estimates tied to inventory, held-for-sale assets, and non-controlling interests.

- **Wholesale vs. retail revenue mix** — Revenue and gross profit presentation
- **Goodwill and indefinite-lived intangible impairment** — Non-cash charges can materially affect earnings and equity
- **Lease accounting for dispensaries and cultivation sites** — Balance sheet leverage and operating expense presentation
- **Inventory and held-for-sale asset estimates** — Asset values and impairment risk

- Revenue mix between wholesale and retail affects comparability
- Store openings and market launches can create quarterly seasonality
- Goodwill and indefinite-lived intangibles require impairment testing
- Lease accounting matters for dispensaries and cultivation facilities
- Inventory and held-for-sale asset estimates can move reported assets

---

*Last updated: 2026-04-29T05:07:42.086548+00:00*
